| ACS | Acute coronary syndrome |
| AF | Atrial fibrillation |
| ASA | Aspirin |
| BARC | Bleeding Academic Research Consortium |
| BMS | Bare metal stent |
| CABG | Coronary artery bypass graft surgery |
| CAD | Coronary artery disease |
| CI | Confidence interval |
| DAPT | Dual antiplatelet therapy |
| DAT | Dual antithrombotic therapy |
| DES | Drug eluting stent |
| DOAC | Direct Oral anticoagulant |
| HR | Hazard ratio |
| ISTH | International Society on Thrombosis and Haemostasis |
| LAA | Left atrial appendage |
| LAAO | Left atrial appendage occlusion |
| MACCE | Major Adverse Cardiovascular and Cerebrovascular Events |
| MI | Myocardial infraction |
| NSTEMI | Non ST-segment Elevated Myocardial Infarction |
| OAC | Oral anticoagulant |
| P2Y12i | Receptor P2Y12 inhibitor |
| PAD | Peripheral arterial disease |
| PCI | Percutaneous coronary intervention |
| PFO | Patent foramen ovale |
| PTCA | Percutaneous transluminal coronary angioplasty |
| PV | Prosthetic Valve |
| RCT | Randomized controlled trial |
| SAPT | Single antiplatelet therapy |
| TAT | Triple antithrombotic therapy |
| TAVI | Transcatheter aortic valve implantation |
| TVMR | Transcatheter mitral valve repair |
| VKA | Vitamin k antagonist |